OpenURL Connection Search

Select item for more details and to access through your institution.

Assessing Preferences for Rare Disease Treatment: Qualitative Development of the Paroxysmal Nocturnal Hemoglobinuria Patient Preference Questionnaire (PNH-PPQ©).
Published in:
Patient Preference & Adherence, 2020, v. 14, p. 705, doi. 10.2147/PPA.S233830
By:
- Kaiser, Karen;
- Yount, Susan E;
- Martens, Christa E;
- Webster, Kimberly A;
- Shaunfield, Sara;
- Sparling, Amy;
- Peipert, John Devin;
- Cella, David;
- Rottinghaus, Scott T;
- Donato, Bonnie MK;
- Wells, Richard;
- Tomazos, Ioannis
Publication type:
Article
Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies.
Published in:
British Journal of Haematology, 2020, v. 191, n. 3, p. 476, doi. 10.1111/bjh.16711
By:
- Peffault de Latour, Régis;
- Brodsky, Robert A.;
- Ortiz, Stephan;
- Risitano, Antonio M.;
- Jang, Jun H.;
- Hillmen, Peter;
- Kulagin, Alexander D.;
- Kulasekararaj, Austin G.;
- Rottinghaus, Scott T.;
- Aguzzi, Rasha;
- Gao, Xiang;
- Wells, Richard A.;
- Szer, Jeff
Publication type:
Article
The First Antibody Responses to DNA Vaccines in Humans.
Published in:
2008
By:
- Rottinghaus, Scott T.;
- Poland, Gregory A.
Publication type:
Letter
One-year efficacy and safety of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria naïve to complement inhibitor therapy: open-label extension of a randomized study.
Published in:
Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720966137
By:
- Schrezenmeier, Hubert;
- Kulasekararaj, Austin;
- Mitchell, Lindsay;
- de Fontbrune, Flore Sicre;
- Devos, Timothy;
- Okamoto, Shinichiro;
- Wells, Richard;
- Rottinghaus, Scott T.;
- Peng Liu;
- Ortiz, Stephan;
- Jong Wook Lee;
- Socié, Gérard
Publication type:
Article
Combination antifungal therapy for invasive aspergillosis: a randomized trial.
Published in:
2015
By:
- Marr, Kieren A;
- Schlamm, Haran T;
- Herbrecht, Raoul;
- Rottinghaus, Scott T;
- Bow, Eric J;
- Cornely, Oliver A;
- Heinz, Werner J;
- Jagannatha, Shyla;
- Koh, Liang Piu;
- Kontoyiannis, Dimitrios P;
- Lee, Dong-Gun;
- Nucci, Marcio;
- Pappas, Peter G;
- Slavin, Monica A;
- Queiroz-Telles, Flavio;
- Selleslag, Dominik;
- Walsh, Thomas J;
- Wingard, John R;
- Maertens, Johan A
Publication type:
journal article
Combination Antifungal Therapy for Invasive Aspergillosis.
Published in:
Annals of Internal Medicine, 2015, v. 162, n. 2, p. 81, doi. 10.7326/M13-2508
By:
- Marr, Kieren A.;
- Schlamm, Haran T.;
- Herbrecht, Raoul;
- Rottinghaus, Scott T.;
- Bow, Eric J.;
- Cornely, Oliver A.;
- Heinz, Werner J.;
- Jagannatha, Shyla;
- Liang Piu Koh;
- Kontoyiannis, Dimitrios P.;
- Dong-Gun Lee;
- Nucci, Marcio;
- Pappas, Peter G.;
- Slavin, Monica A.;
- Queiroz-Telles, Flavio;
- Selleslag, Dominik;
- Walsh, Thomas J.;
- Wingard, John R.;
- Maertens, Johan A.
Publication type:
Article

Found: 6

Assessing Preferences for Rare Disease Treatment: Qualitative Development of the Paroxysmal Nocturnal Hemoglobinuria Patient Preference Questionnaire (PNH-PPQ©).

Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies.

The First Antibody Responses to DNA Vaccines in Humans.

One-year efficacy and safety of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria naïve to complement inhibitor therapy: open-label extension of a randomized study.

Combination antifungal therapy for invasive aspergillosis: a randomized trial.

Combination Antifungal Therapy for Invasive Aspergillosis.